Justice Department, Antitrust Division
Document Headings Document headings vary by document type but may contain the following: the agency or agencies that issued and signed a document the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to the agency docket number / agency internal file number the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. Department of Justice Antitrust Division Notice is hereby given that, on October 16, 2018, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (“the Act”), Medical CBRN Defense Consortium (“MCDC”) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act's provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Allegheny-Singer Research Institute DBA AHN Institute, Pittsburgh, PA; Allotropic Tech, Halethorpe, MD; ASELL LLC, Owings Mills, MD; Clear Scientific LLC, Cambridge, MA; FLIR Detection, Inc., Stillwater, OK; FORGE Life Sciences, LLC, Doylestown, PA; IDBiologics, Inc., Nashville, TN; ImmPORT Therapeutics Inc. DBA Antigen Discovery Inc., Irvine, CA; Polo Custom Products, Topeka, KS; SIGA Technologies, Inc., New York, NY; The Albert Sabin Vaccine Institute, Inc. DBA Sabin Vaccine Institute, Washington, DC; VenatoRx Pharmaceuticals, Inc., Malvern, PA; and Windgap Medical, Inc., Watertown, MA, have been added as parties to this venture. Also, Artificial Cell Technologies, Inc., New Haven, CT; Celdara Medical, LLC, Lebanon, NH; HORIBA Instruments, Inc., Edison, NY; Macromoltek, Austin, TX; Philips Healthcare, Andover, MA; Phosphorex Inc., Hopkinton, MA; PPD Development LP, Wilmin…
Citation: 83 FR 55739